-Maarten J Postma Researcher Activity Profile

Research Author Detailed Information 

Maarten J Postma Publication Rate By Year

Maarten J Postma has published 1 paper(s) in 2005, 1 paper(s) in 2006, 2 paper(s) in 2007, 7 paper(s) in 2008, for a total of 11 research publications in total.

Maarten J Mj Postma Author Information

LAST NAME: postma

FIRST NAME: Maarten J

INITIALS: mj

AFFILIATION:

Papers

Maarten J Postma's Publication Record

1. Drug costs developments after patent expiry of enalapril, fluoxetine and ranitidine: a study conducted for the Netherlands. Year Published: 2005
Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University for Drug Exploration (GUIDE), Groningen, The Netherlands.
2. The use of health economics to guide drug development decisions: Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach. Year Published: 2007
Graduate Schools SHARE & GUIDE, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, The Netherlands.
3. Cost effectiveness of itraconazole in the prophylaxis of invasive fungal infections. Year Published: 2007
Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, The Netherlands.
4. Evaluation of the leukocyte esterase test (LET) as pre-screening test to reduce costs for national population-based Chlamydia trachomatis screening programs. Year Published: 2006
5. Cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in HIV infected patients previously exposed to antiretroviral therapy in the Netherlands. Year Published: 2008
University Center for Pharmacy, University of Groningen, The Netherlands. g.hubben@rug.nl.
6. Estimation and prediction of the HIV-AIDS-epidemic under conditions of HAART using mixtures of incubation time distributions. Year Published: 2008
Organon N.V., P.O. Box 20, Oss 5340 BH, The Netherlands.
7. Estimation and prediction of the HIV-AIDS-epidemic under conditions of HAART using mixtures of incubation time distributions. Year Published: 2008
Organon N.V., P.O. Box 20, Oss 5340 BH, The Netherlands. siem.heisterkamp@organon.com
8. Pharmacoeconomics in nephrology: considerations on cost-effectiveness of screening for albuminuria. Year Published: 2008
9. Health economic methodology illustrated with recent work on Chlamydia screening: the concept of extended dominance. Year Published: 2008
Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands. m.j.postma@rug.nl
10. Cost-utility of repeated screening for Chlamydia trachomatis. Year Published: 2008
Groningen University Institute for Drug Exploration/University of Groningen Research Institute of Pharmacy, Groningen, The Netherlands.
11. Cost-utility of repeated screening for Chlamydia trachomatis. Year Published: 2008
Groningen University Institute for Drug Exploration/University of Groningen Research Institute of Pharmacy, Groningen, The Netherlands.